This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weiner, M. F. Articles by Gray, K. F. Search for Related Content PubMed Articles by Weiner, M. F. Articles by Gray, K. F. Social Bookmarking                         What's this?

Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease

Kevin F. Gray, MD

Department of Psychiatry and Neurology and Alzheimer's Disease Center, University of Texas Southwestern Medical Center, Dallas, Texas

The behavioral and emotional symptoms of Alzheimer's disease (AD) are frequently the most important clinical considerations for physicians, who can choose to employ behavioral/environmental (psychosocial) or psychopharmacologic measures to deal with such symptoms. The appropriate use of these modalities to treat behavioral/emotional symptoms isfacilitated by using a frame of reference that includes information as to where, when, and with whom symptoms occur, with what medication or medical condition, how often, and how troubling or dangerous to patient, caregiver; or others. It should also include patients' ability to communicate, learn and comprehend. This frame of reference can help clinicians appropriately balance their use of psychosocial and psychopharmacologic interventions with AD patients.

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 9, No. 4, 6-12 (1994)
DOI: 10.1177/153331759400900403


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?